SoylentNews is people
SoylentNews is powered by your submissions, so send in your scoop. Only 19 submissions in the queue.
SoylentNews
Submitted via IRC for SoyCow1984
Drug companies are sitting on generics—43% of recently approved aren't for sale
Of the more than 1,600 generic drugs approved by the Food and Drug Administration since January of 2017, more than 700—or 43 percent—are not for sale in the US, according to a new analysis by Kaiser Health News.
The finding means that many pricy, brand-name drugs are not facing the competition that could help drive down soaring prices. Among the drugs missing in action are generic versions of the expensive blood thinner Brilinta and the HIV medication Truvada. Moreover, of the approved drugs that would offer a brand-name drug its first competition, 36 percent are being held off the market, the analysis found.
This discussion has been archived.
No new comments can be posted.
Drug Companies are Sitting on Generics—43% of Recently Approved Aren’t for Sale
|
Log In/Create an Account
| Top
| 48 comments
| Search Discussion
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
April 1
This is the day upon which we are reminded of what we are on the other three
hundred and sixty-four.
-- Mark Twain, "Pudd'nhead Wilson's Calendar"
(Score: 3, Insightful) by Azuma Hazuki on Tuesday February 12 2019, @01:49AM
Oh, on the contrary: regulatory capture is both the end result and the apotheosis of free-market capitalism; why, even the very government is for sale! And for bonus shits'n'giggles, the greedheads then tell people that *regulation itself* is bad.
To paraphrase: regulations don't kill people, people do.
I am "that girl" your mother warned you about...